JOINT Corp (JYNT): M&A transaction — The Joint Corp. closes sale of 31 clinics for $11.13M, acquires NW region RD rights

JOINT Corp

Sold 31 company-owned clinics in AZ/NM to Joint Ventures, LLC for $11.13M (includes $8.3M cash).
Acquired regional developer rights for Northwest region (46 franchised clinics, 30 future sites).
Acquired RD rights generated $855,000 in royalties/fees in trailing 12 months ended March 31, 2025.
Pro forma shows net income from continuing operations of $88,979 for Q1 2025 vs prior loss of $506,021.
Transaction expected to reduce commission obligations and increase operating margin.

item 2.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

JOINT Corp completed a disposition involving Joint Ventures, LLC for $11.13 million (closed 2025-06-30).

Action: disposition
Counterparty: Joint Ventures, LLC
Consideration: $11.13 million
Closing: 2025-06-30

Exact text from the filing

On June 30, 2025, we completed the previously announced sale of the assets of, and the franchise rights to, 31 company-owned and managed clinics located in Arizona and New Mexico (the “Joint Ventures Transaction”) to Joint Ventures, LLC, a Nevada limited liability company and our largest franchisee (“Joint Ventures”), for an aggregate purchase price of $11.13 million, subject to certain adjustments, pursuant to an Asset Purchase Agreement, dated as of June 23, 2025, by and between us and Joint Ventures.

View on SEC.gov

31 m&a transactions filed in the last 30 days. Browse all m&a transactions →

JOINT Corp filing history →

Source: SEC EDGAR

accession 0001612630-25-000009

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.